Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against MannKind Corp. (“MannKind” or the “Company”) (Nasdaq: MNKD). Investors who purchased or otherwise acquired shares between August 10, 2015 and January 5, 2016, (the “Class Period”), are encouraged to contact the firm in advance of the March 15, 2016, lead plaintiff motion deadline.

If you are a shareholder who suffered a loss during the Class Period, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 708, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the complaint, the Company failed to disclose that, contrary to the Company’s assurances, the mandated pulmonary testing or spirometry was still a significant issue impeding sales of Afrezza.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.